Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.73 | N/A |
| PEG Ratio (TTM) | 0.71 | N/A |
| P/S Ratio (TTM) | 1.55 | N/A |
| P/B Ratio (TTM) | 1.61 | N/A |
| P/FCF Ratio (TTM) | 12.47 | N/A |
| Price to 5YR AVG Earnings Ratio | 2.18 | N/A |
| Price to 5YR AVG FCF Ratio | 1.40 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.90% | N/A |
| ROE (TTM) | 8.88% | N/A |
| Net Profit Margin (TTM) | 8.98% | N/A |
| ROIC 5YR AVG | 16.06% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 150.53% | 1.99% | 7.81% |
| Revenue | 1.98% | 31.64% | 21.02% |
| Net Income | 145.19% | 4.05% | 7.80% |
| Cash Flow | 3.60% | 3.19% | 8.18% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.37 | N/A |
| Quick Ratio (TTM) | 1.37 | N/A |
| D/E Ratio (TTM) | 0.21 | N/A |
| Interest Coverage (TTM) | 8.73 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.54 | N/A |
| LTL to 5YR AVG FCF | 1.17 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.13% | N/A |